Cardiovascular morbidity and the use of inhaled bronchodilators
Open Access
- 1 March 2008
- journal article
- research article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 3 (1) , 163-169
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 22 references indexed in Scilit:
- Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan CanadaAnnals of Epidemiology, 2006
- Acute Electrophysiologic Effects of Inhaled Salbutamol in HumansChest, 2005
- Association between chronic heart failure and inhaled β-2-adrenoceptor agonistsAmerican Heart Journal, 2004
- Myocardial Injury During Standard Treatment of an Adult with Status AsthmaticusJournal of Asthma, 2004
- Risk of Mortality and Heart Failure Exacerbations Associated With Inhaled β-Adrenoceptor Agonists Among Patients With Known Left Ventricular Systolic DysfunctionaChest, 2003
- Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?Respiratory Medicine, 2003
- Inhaled short acting beta agonist use in COPD and the risk of acute myocardial infarctionThorax, 2003
- Association Between Inhaled β-Agonists and the Risk of Unstable Angina and Myocardial InfarctionChest, 2002
- Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway diseaseThorax, 2000
- Sudden Cardiac Death in Bronchial Asthma, and Inhaled Beta-Adrenergic AgonistsChest, 1992